People · Operator
Named in public records as an officer, director or promoter · active 2020–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | — | Biotechnology | Series B | $46.9M | $160.9M | 2024 |
| TuHURA Biosciences, Inc./NV | — | Biotechnology | Series B | $41.6M | $6.1M | 2025 |
| Morphogenesis Inc | — | Biotechnology | Series B | $27.9M | $15.1M | 2023 |
| Ocuphire Pharma, Inc. | — | Biotechnology | Seed | $3.9M | $94.4M | 2020 |
James Manuso at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Manuso on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cam Gallagher | 2 | 7 |
| Sean Ainsworth | 2 | 5 |
| Mina Sooch | 2 | 5 |
| George Ng | 2 | 4 |
| James Bianco | 2 | 4 |
| Bernhard Hoffmann | 2 | 2 |
| Dan Dearborn | 2 | 2 |
| Alan List | 2 | 2 |
| Robert Hoffman | 1 | 5 |
| Dennis Brown | 1 | 5 |
| Richard Rodgers | 1 | 4 |
| Keith Murphy | 1 | 4 |
| James S. Manuso | 1 | 3 |
| SAIID ZARRABIAN | 1 | 3 |
| WILLIAM GARNER | 1 | 2 |
| John K. Bell | 1 | 2 |
| Richard J. Rodgers | 1 | 2 |
| Jeffrey Bacha | 1 | 2 |
| Laura Johnson | 1 | 2 |
| Susan Benton | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.